CAS: 1428935-60-7 - Durvalumab
Formel:Unspecified
- Synonyme:
- MED 14736
- Immunoglobulin G1, anti-(human CD antigen CD274) (human monoclonal MEDI4736 heavy chain), disulfide with human monoclonal MEDI4736 κ-chain, dimer
- Durvalumab
- MEDI 4736
- Immunoglobulin G1, anti-(human protein B7-H1) (human monoclonal MEDI4736 heavy chain), disulfide with human monoclonal MEDI4736 κ-chain, dimer
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | Durvalumab REF: TM-T11126CAS: 1428935-60-7 | SDS-PAGE:97.2%;SEC-HPLC:95.3% | 213,00 €~1.990,00 € | Fr 13 Dez 24 |
 | Durvalumab REF: 3D-DHC93560CAS: 1428935-60-7 | Min. 95% | Nachfragen | Do 23 Jan 25 |
Durvalumab
CAS:1428935-60-7
Durvalumab is a humanized antibody for cancer, inhibiting PD-L1/PD-1 and CD80 interactions at very low …
Reinheit:
SDS-PAGE:97.2%;SEC-HPLC:95.3%
Farbe und Form:
Liquid
Molekulargewicht:
146.03 kDa
Ref: TM-T11126
| 1mg | 213,00 € | ||
| 5mg | 506,00 € | ||
| 10mg | 727,00 € | ||
| 25mg | 1.103,00 € | ||
| 50mg | 1.486,00 € | ||
| 100mg | 1.990,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Freitag 13. Dezember 2024
Durvalumab
CAS:1428935-60-7
Durvalumab is a human immunoglobulin G1 (IgG1) monoclonal antibody that binds to PD-L1, a protein …
Reinheit:
Min. 95%
Farbe und Form:
Powder
Molekulargewicht:
1,000 g/mol
Ref: 3D-DHC93560
| 1mg | 740,00 € | ||
| 2mg | 986,00 € | ||
| 5mg | 1.392,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 23. Januar 2025
